FDA Brief

Warning letters Drugs

FDA warning letter to

Shuzy Rock Inc.

High riskIssued Sep 1, 2022Posted Nov 29, 2022Division of Pharmaceutical Quality Operations I

FDA warns Shuzy Rock Inc. of adulterated hand sanitizers made under insanitary conditions and found below labeled alcohol strength.

What happened

FDA inspected Shuzy Rock's South Plainfield, NJ drug manufacturing facility from January 11 to February 14, 2022. Investigators found insanitary conditions, inadequate cleaning and water controls, no functioning quality unit, and no release testing. FDA lab testing of U.S. market hand sanitizer batches found ethanol at 48–57% instead of labeled 65%, and 55% instead of 70%.

What FDA found

  1. The company made drugs under insanitary conditions, with refuse, spills, broken tiles, soiled equipment, and inadequate cleaning.

    FD&C Act section 501(a)(2)(A), 21 U.S.C. 351(a)(2)(A)
  2. The company's hand sanitizer was subpotent: batches labeled 65% ethanol contained 48–57%, and a batch labeled 70% contained 55%.

    FD&C Act section 501(c), 21 U.S.C. 351(c)
  3. The company lacked a functioning quality control unit to approve or reject materials and products, investigate problems, and handle complaints or recalls.

    21 CFR 211.22
  4. The company lacked adequate written production and process controls, including critical manufacturing parameters and executed batch records for distributed hand sanitizer.

    21 CFR 211.100(a)
  5. The company did not perform adequate laboratory testing before releasing batches to confirm identity and strength, and could not provide release test results.

    21 CFR 211.165(a)
  6. The company did not register its establishment or list its drug products with FDA.

    FD&C Act section 510, 21 U.S.C. 360; 21 CFR 207.17(a), 207.41

What FDA wants

FDA tells the company to correct the violations promptly and respond in writing within 15 working days with corrective actions, investigations, batch records, and remediation plans. If the company resumes drug manufacturing, FDA says it must notify the office first and engage a qualified CGMP consultant.

Who should pay attention

  • brands or distributors that sold Premium Nature hand sanitizer
  • contract manufacturers and repackers of OTC drugs or cosmetics
  • companies relying on supplier CGMP and FDA registration/listing status

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. CNC Noodle Corporation

    FDA warned CNC Noodle Corporation that its Hayward, California noodle plant had insanitary conditions, no pathogen or allergen controls, and mislabeled products.

    High risk
  2. ABC Food Corp

    ABC Food Corp's ready-to-eat rice noodles and tofu were made without required hazard analysis and preventive controls.

    High risk
  3. Rama Food Manufacture Corp.

    FDA warns Rama Food Manufacture after inspections found insanitary conditions and preventive-control failures at its California ready-to-eat rice noodle plants.

    High risk
  4. Lewis Sausage Company Inc.

    FDA found Salmonella and Listeria in contract-made pet food from Lewis Sausage and says its pathogen controls are inadequate.

    High risk